Takekazu Aoyama

Protracted survival after resection of metastatic uveal melanoma

Takekazu Aoyama, Michael J. Mastrangelo, David Berd et al. · Cancer · 2000 · 133 citations · Full text

Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial

Martin Reck, Tudor–Eliade Ciuleanu, Michael Schenker et al. · European Journal of Cancer · 2024 · 57 citations

A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer

Jaffer A. Ajani, Mikhail Abramov, Igor Bondarenko et al. · Annals of Oncology · 2017 · 44 citations · Full text

Gastrointestinal Oncology, Medicine, Phase Iii Trial +7

Long-Term Survival Outcomes With First-Line Nivolumab Plus Ipilimumab–Based Treatment in Patients With Metastatic NSCLC and Tumor Programmed Death-Ligand 1 Lower Than 1%: A Pooled Analysis

Solange Peters, Luis Paz‐Ares, Martin Reck et al. · Journal of Thoracic Oncology · 2024 · 22 citations · Full text

Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA

David P. Carbone, Tudor–Eliade Ciuleanu, Manuel Cobo et al. · ESMO Open · 2025 · 11 citations · Full text